The Pharmacoeconomics Research Unit at Cancer Care Ontario consists of a multidisciplinary team with expertise in using health economics to inform and improve decision making.
We support the Ontario Ministry of Health and Long Term Care and Cancer Care Ontario, the Ontario Public Drug Programs (OPDP), the Committee to Evaluate Drugs/Cancer Care Ontario (CED-CCO) subcommittee and the New Drug Funding Program (NDFP) in their pharmacoeconomic (PE) needs:
- Conducting, evaluating and explaining PE analysis of cancer drugs under review for funding consideration;
- Providing technical guidance in the area of health economics and health services research in cancer control.
The Unit’s research is organized into three main themes: